How does coalition advocacy shape federal research funding? Tannaz Rasouli of the Ad Hoc Group for Medical Research joins our upcoming Advocacy Town Hall to discuss the FY 2027 funding recommendation for NIH and how a coalition works together to strengthen NIH investment. buff.ly/BdZDtHw

#Postdocs! Going on academic job market? Apply for SDB GetHIRED! Take stock of what you want, know your options, prepare an outstanding job packet, organize your research & chalk talks, perfect your interview. Deadline: March 5 sdbonline.org/gethired

This week at Stanford: The FASEB Journal’s Integrative Bioscience Symposium featuring a full day of talks + keynote from Nobel Laureate Carolyn Bertozzi. Spots are limited and filling fast. Register → buff.ly/mxZPxRA

Mark your calendar for March 3! Tannaz Rasouli, Executive Director of the Ad Hoc Group for Medical Research, will break down the FY 2027 funding recommendation for NIH and the power of coalition advocacy at our FASEB Advocacy Town Hall. Don't miss it! Register here ➡️ buff.ly/WZPrWuD

Early-career researchers! Want to influence biosciences’ future? FASEB is reserving 3 voting seats on our Board & Science Policy Committee. This is your opportunity to bring your perspective directly into high‑level decisions that impact the biological & biomedical research community. bit.ly/3CuOCnu

Check out the global speaker line up. several travel awards and slots for short talks open. Don’t miss this summer @faseborg.bsky.social events.faseb.org/event/TGF-B/...

📰 The latest Washington Update is here! Get up to speed on what’s happening on Capitol Hill, key developments in science policy, federal agency news, and current advocacy efforts shaping the research landscape. Read the full issue ➡️ buff.ly/Tvt3Jeh

#WeAreHiring! FASEB is seeking an Executive Administrator to support the ED/CEO, streamline governance operations, and manage strategic projects. Learn more about the role and apply today: buff.ly/EBdOoS8 #SciJobs #FASEB #Careers #NowHiring

Calling early-career faculty + emerging investigators 📣 Join The FASEB Journal at Stanford on March 6 for From Molecules to Medicine, featuring keynote speaker Nobel Laureate Carolyn Bertozzi and a lineup of cutting-edge biomedical research talks. Register now: buff.ly/mxZPxRA

Don't miss our virtual Advocacy Town Hall on March 3! Get insights from Capitol Hill, hear the latest news in science policy, and engage in a live discussion with the research community. Save your spot: buff.ly/tc6c9uQ

HCS Members: Get caught up on the latest science policy issues for FREE with The Washington Update: faseb.org/journals-and... #scicomm #AcademicChatter #sciencepolicy @faseborg.bsky.social

NIGMS Advisory Council reviews updates to training and workforce development programs, including a streamlined predoctoral research training framework. Read more in the Washington Update: buff.ly/Z8spzb0

FASEB sent a letter to Senate HELP Committee Chair Bill Cassidy thanking the committee for its hearing on modernizing NIH and for acknowledging recent actions that have created uncertainty across the U.S. research enterprise. Read our letter ➡️ buff.ly/1zITnCP

#WeAreHiring! FASEB is seeking an Executive Administrator to support the ED/CEO, streamline governance operations, and manage strategic projects. Learn more about the role and apply today: buff.ly/EBdOoS8 #SciJobs #FASEB #Careers #NowHiring

SDB is sad to announce the passing of Gail R. Martin (1944-2026) after a short illness in San Francisco. Martin served as SDB President in 2007 and was the recipient the Conklin Medal in 2002 and the @FASEBorg Excellence in Science Award in 2011. bit.ly/4aIfu5d

#ICYMI FASEB’s ASNAM Initiative published their first article! Authored by leading musculoskeletal researchers, it outlines why animal models remain essential to advancing musculoskeletal research amid growing use of alternative methods. Read it here: buff.ly/X72tqwX

The latest in the Washington Update: #NIH Council of Councils reviews a proposed DPCPSI reorganization and new initiatives to strengthen rigor, replication, and reproducibility in #biomedical research. buff.ly/scF7oXw

NIH Director Jay Bhattacharya testifies before the Senate HELP Committee on vaccine safety, funding policies, clinical trial disruptions, and the future direction of #NIH research. Read more in the Washington Update: buff.ly/bQA7kol

Not sure how to submit programmatic requests effectively? Don’t miss our Advocacy Town Hall on February 17 for a walkthrough from our Associate Director of Legislative Affairs, Ellen Kuo. Save your spot: buff.ly/LOmSM8i

📅 Mark your calendar! Join FASEB’s Advocacy Town Hall on February 17 at noon ET! Learn how to submit programmatic requests with guidance from Ellen Kuo, Associate Director of Legislative Affairs at FASEB. Register here: buff.ly/LOmSM8i

📰 The latest Washington Update is here! Get up to speed on what’s happening on Capitol Hill, key developments in science policy, federal agency news, and current advocacy efforts shaping the research landscape. Read the full issue ➡️ buff.ly/wJLQb5q?utm_...

For Love Data Week 💙 FASEB journals partner with Dryad so authors can upload datasets during peer review, assign persistent identifiers, and make data openly available after publication: buff.ly/8Iw7HnQ Because transparent, reusable data helps science move forward. #LoveData26

📢 Now published: the first article from FASEB’s ASNAM Initiative! Authored by leading musculoskeletal researchers, it outlines why animal models remain essential to advancing musculoskeletal research amid growing use of alternative methods. Read the full article: buff.ly/X72tqwX

Stay informed on what’s happening on Capitol Hill, the latest science policy developments, advocacy efforts, and news from federal science agencies. Subscribe to the Washington Update newsletter here: buff.ly/kR1f0mn

#ICYMI FASEB issues a statement strongly supporting #NPRCs amid ongoing state-level animal rights campaigns & growing federal pressure. NPRCs are essential national shared resources that operate with transparency, accountability, & the highest standards of scientific integrity. buff.ly/iDPxGUR

FASEB issues a statement supporting the National Primate Research Centers amid ongoing state-level animal rights campaigns and growing federal pressure on the institutions. OHSU Board will hold a public meeting on the future of the Oregon NPRC on February 9. Read our full statement:

🧠 One strategy, multiple targets. This open-access study from FASEB Journal shows how pairing isoquercetin with zafirlukast can reduce tumor growth, inflammation, and clot-related signaling in ovarian cancer—highlighting a new way to tackle cancer and thrombosis together. 🔗

#ICYMI: 📝 FASEB's comments to NSF on its FY 2026–2030 Strategic Plan highlights how timely communication and active engagement with the scientific community help move the agency’s goals forward. Read our comments here:

🧬🧠 Inflammation doesn’t stop when a stroke ends. This study links a specific immune signaling pathway (CCL11–CCR3) to damaging cell death in brain support cells after stroke—fueling inflammation and harming neuron connections. 🔗

🧬🦷 When force meets biology. This FASEB Journal review breaks down how orthodontic pressure can disrupt tooth root homeostasis, triggering inflammation and cell damage that lead to root resorption—and why understanding these mechanisms is key to safer orthodontic treatments. 🔗 buff.ly/CiakNqS

📢 Why do coalitions matter in advocacy? Hear from Leland Cogliani of Lewis-Burke Associates LLC at FASEB’s Advocacy Town Hall as he breaks down the power of collective action. Register for FREE: buff.ly/001itxL

📢 Coalitions amplify voices and strengthen outcomes. Don't miss FASEB’s upcoming Advocacy Town Hall to learn from Leland Cogliani of Lewis-Burke Associates LLC about how coalition advocacy works and why it matters. 🔗https://buff.ly/001itxL

🧪🌿 From plants to pathways. This review in The FASEB Journal summarizes how β-caryophyllene, a plant-derived compound, may protect the liver by calming inflammation, reducing scarring, and improving fat metabolism—while underscoring the need for clinical validation. 🔗 buff.ly/AyT3vBc

📝 FASEB submits comments to NSF on its FY 2026–2030 Strategic Plan, highlighting how timely communication and active engagement with the scientific community help move the agency’s goals forward. Read the comments: buff.ly/goWQag5

🩺🧬 Peritoneal dialysis saves lives—but long-term use can lead to tissue scarring. This review in FASEB Journal breaks down how faulty cell-to-cell communication drives peritoneal fibrosis and highlights new strategies to slow damage and improve outcomes for kidney patients. 🔗 buff.ly/YBH477y

NIH announces several developments at the agency, including leadership updates, a proposed reorganization within DPCPSI, and updated OLAW guidance on prompt reporting. Read more in the Washington Update: buff.ly/oXn9t7X

🧬🦠 Flu viruses don’t act alone—they rely on our cells. This review in the FASEB Journal explains how noncoding RNAs inside human cells can either support or suppress influenza A infection, pointing toward new ways to control the virus. 🔗 buff.ly/EIwrFiR

A federal appeals court will fast-track the review of the Trump administration’s $100,000 supplemental H-1B visa fee, which could significantly affect universities and research employers relying on international talent. Read more in the Washington Update: buff.ly/YFJ5UR3

📰 The latest in the Washington Update: NIH releases a new trans-agency NOFO for the new PF5 award structure for research collaborations with international components. Effective for grant submissions on or after May 25. Read more: buff.ly/rfefVCU

NIH is seeking public input on proposed updates to its Controlled-Access Data and Genomic Data Sharing policies to strengthen protections for human participant research data. Comments due March 18. Read more in the Washington Update: buff.ly/1780AFf

New issue of Washington Update just dropped! Stay informed on what’s happening on Capitol Hill, the latest science policy developments, advocacy efforts, and news from federal science agencies. Read the full issue here ➡️ buff.ly/ikLuEge

Join us TODAY to rally advocates nationwide for research funding that saves lives and drives innovation. Congress has advanced NIH funding. Lawmakers must act swiftly to pass the bill so that lifesaving research isn’t delayed. Call or email your Member of Congress: hubs.ly/Q03_1xcG0 #UnitedForCures

Today is United for Cures’ Social Media Day of Action, and FASEB is proud to participate. Congress has taken an important step by advancing FY26 funding for medical research. Now, lawmakers must act swiftly to pass the bill, so lifesaving research isn’t delayed. buff.ly/itnx7NR #CuresCantWait

🍵 Research spotlight! An in vitro study in The FASEB Journal on tea catechins inhibiting intestinal GLUT sugar transporters is cited in The State’s health coverage on blood sugar management. What tea do you need to drink? Read more: buff.ly/kHnZYQ3

Tomorrow is @unitedforcures.bsky.social’s National Day of Action! Join FASEB in urge Congress to increase federal funding for medical research in FY 2026. Register here:🔗 buff.ly/xbLm5Yn #SupportCures #FundMedicalResearch #CuresCantWait

Happening today at noon ET! FASEB's Ellen Kuo will share what advocacy strategies are effective, what’s changed, and how advocates can succeed by adopting new approaches grounded in precision, patience, and credibility. Session is FREE and open to everyone! Registration required: buff.ly/8LKSgD2

ICYMI: Lifesaving cures start with research, & that research depends on sustained federal investment. On January 21, FASEB is joining United for Cures’ National Day of Action to urge Congress to increase federal funding for medical research in FY26. Will you join us? 🔗 buff.ly/xbLm5Yn #CuresCantWait

Why do kidney injuries sometimes turn into chronic disease? 🩺 This FASEB Journal review explains how damaged cells that stop working but don’t go away can drive inflammation, scarring, and even kidney cancer and how new therapies aim to target them. Read the review: buff.ly/YBsYFnh

Advocacy is evolving. Join our Advocacy Town Hall on Jan 20 for insights from FASEB's Ellen Kuo. She will share effective advocacy strategies, identify approaches that are falling short, & discuss how advocates can adapt with precision, patience, and credibility in 2026. Register: buff.ly/YlSuipL

At FASEB, we believe that lifesaving medical breakthroughs begin with research, & that research relies on sustained federal investment. That’s why we’re joining United for Cures’ National Day of Action on Jan. 21! We urge Congress to increase federal funding for research in FY26.